Anixa Biosciences Inc

Pharmaceutical Preparations | SIC: 2834
Phone: 408-708-9808
CIK: 0000715446
EIN: 112622630
State Location: CA
State of Inc.: DE
Tickers:
  • Nasdaq:ANIX

Form: 10-Q

Filing Date: 10 Jun 2026
Report Date: 30 Apr 2026
Accepted: 10 Jun 2026 02:15 p.m.
Accession Number: 0001493152-26-028105
Act: 34
File Number: 001-37492
Film Number: 261079862

Documents

Primary Document: 10-Q
Accepted: 10 Jun 2026 02:15 p.m.